Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) investigated in research for its potential to stimulate endogenous growth hormone (GH) release. In preclinical and early clinical studies, it has been explored for effects on lipolysis, visceral fat metabolism, and body composition in models of metabolic imbalance, such as HIV-associated lipodystrophy simulations. Researchers study its mechanisms in modulating GH/IGF-1 pathways and tissue remodeling, with applications in endocrine and metabolic research. For research use only.